Menu
Sign In Search Podcasts Libraries Charts People & Topics Add Podcast API Blog Pricing

John Hamilton

๐Ÿ‘ค Speaker
See mentions of this person in podcasts
492 total appearances

Appearances Over Time

Podcast Appearances

NPR News Now
NPR News: 11-01-2025 10PM EDT

A genetic analysis of the nerve cells found a distinctive pattern of gene mutations in brains with CTE.

NPR News Now
NPR News: 11-01-2025 10PM EDT

The pattern was not present in brains that appeared healthy despite exposure to head trauma.

NPR News Now
NPR News: 11-01-2025 10PM EDT

Researchers say the mutations associated with CTE are similar to those found in brain cells from people with Alzheimer's disease.

NPR News Now
NPR News: 11-01-2025 10PM EDT

Both conditions are marked by an accumulation of a protein called tau.

NPR News Now
NPR News: 11-01-2025 10PM EDT

John Hamilton, NPR News.

NPR News Now
NPR News: 10-17-2025 4AM EDT

The study involved 92 healthy people who were 65 and older.

NPR News Now
NPR News: 10-17-2025 4AM EDT

Half spent 30 minutes a day for 10 weeks playing video games like Solitaire and Candy Crush.

NPR News Now
NPR News: 10-17-2025 4AM EDT

The other half did exercises from a demanding cognitive training program called BrainHQ.

NPR News Now
NPR News: 10-17-2025 4AM EDT

Etienne de Villers-Sidani of McGill University says in people who got the training, levels of a key chemical messenger increased in a brain area involved in making decisions.

NPR News Now
NPR News: 10-17-2025 4AM EDT

De Villers-Sidani said the chemical messenger, called acetylcholine, typically declines by about 2.5 percent every 10 years starting in middle age.

NPR News Now
NPR News: 10-17-2025 4AM EDT

So cognitive training, he says, rolled back the clock by about a decade.

NPR News Now
NPR News: 10-17-2025 4AM EDT

John Hamilton, NPR News.

NPR News Now
NPR News: 10-16-2025 8AM EDT

Feeling heartbroken?

NPR News Now
NPR News: 10-16-2025 8AM EDT

People who inherit two copies of a gene called ApoE4 face at least 10 times the average risk for Alzheimer's.

NPR News Now
NPR News: 10-16-2025 8AM EDT

But Dr. Susan Abushakra of the biotech firm Alzeon says existing treatments often cause dangerous side effects in these people.

NPR News Now
NPR News: 10-16-2025 8AM EDT

So Alzion has been testing a drug that appears to be safer but has yet to prove its effectiveness.

NPR News Now
NPR News: 10-16-2025 8AM EDT

In a study of 325 people with two copies of the ApoE4 gene, the drug failed to help people with more severe symptoms of Alzheimer's.

NPR News Now
NPR News: 10-16-2025 8AM EDT

But in people with milder symptoms, the drug helped preserve memory and thinking and dramatically reduced brain atrophy.

NPR News Now
NPR News: 10-16-2025 8AM EDT

John Hamilton, NPR News.

NPR News Now
NPR News: 10-10-2025 11AM EDT

In Alzheimer's and other neurodegenerative diseases, nerve cells decide to self-destruct long before they should.